BRZE Stock Cash Flow Statements

Braze Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Braze Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-07-31	2025-04-30	2025-01-31	2024-10-31	2024-07-31	2024-04-30	2024-01-31	2023-10-31	2023-07-31	2023-04-30	2023-01-31	2022-10-31	2022-07-31	2022-04-30	2022-01-31

cash flows from operating activities:
net income	-27,763,000	-35,641,000	-17,064,000	-28,127,000	-23,149,000	-35,707,000	-28,578,000	-30,976,000	-32,049,000	-38,826,000	-33,808,000	-33,892,000	-33,413,000	-39,633,000	-43,343,000
adjustments to reconcile net income to net cash from operating activities:
stock-based compensation	37,555,000	30,643,000	27,956,000	28,428,000	30,136,000	28,620,000	24,271,000	23,959,000	24,823,000	24,179,000	18,849,000	19,141,000	17,282,000	16,971,000	29,144,000
amortization of deferred contract costs	10,030,000	9,421,000	9,010,000	9,025,000	8,666,000	8,313,000	8,104,000	7,743,000	7,281,000	6,660,000	6,391,000	6,264,000	5,577,000	5,407,000	4,537,000
depreciation and amortization	4,766,000	2,606,000	2,747,000	2,636,000	2,606,000	2,126,000	1,881,000	2,237,000	1,319,000	1,526,000	1,692,000	1,026,000	935,000	965,000	650,000
benefit from credit losses	368,000	232,000	174,000	1,788,000	-299,000	668,000	303,000	423,000	700,000	594,000	479,000	483,000	-12,000	-143,000
value of common stock donated to charity	751,000	1,109,000	1,012,000	1,417,000			1,371,000	1,427,000			0	0	0	4,260,000
amortization of (discount) premium on marketable securities	-255,000	-399,000	-474,000	-562,000	-556,000	-487,000
non-cash foreign exchange (gain) loss	-18,000	227,000				-295,000
fair value adjustments to contingent consideration			0	-86,000	0	-137,000
other	19,000	9,000	-153,000	-286,000	7,000	280,000	-485,000	-358,000	474,000	20,000	795,000	-264,000
changes in operating assets and liabilities:
accounts receivable	2,441,000	9,108,000	-5,136,000	-20,916,000	10,813,000	9,876,000	-21,277,000	-1,657,000	-2,120,000	11,046,000	-20,527,000	-10,745,000	-5,362,000	21,984,000	-28,664,000
prepaid expenses and other current assets	1,889,000	3,147,000	-5,264,000	639,000	-1,020,000	-984,000	-5,359,000	3,975,000	-2,774,000	745,000	-1,494,000	1,980,000	-505,000	3,615,000	-13,179,000
deferred contract costs	-12,944,000	-11,870,000	-13,407,000	-12,755,000	-11,279,000	-10,730,000	-12,510,000	-11,591,000	-11,539,000	-9,479,000	-9,246,000	-6,562,000	-6,456,000	-8,205,000	-11,050,000
rou assets and liabilities	96,000	-410,000	-184,000	-184,000	785,000	1,522,000	2,372,000	912,000	286,000	705,000	865,000	-127,000	1,738,000	879,000
other assets	-8,048,000	-403,000	477,000	-1,176,000	393,000	277,000	553,000	635,000	-579,000	-380,000	678,000	512,000	-93,000	614,000	-730,000
accounts payable	-181,000	-978,000	-586,000	-1,682,000	156,000	-1,800,000	560,000	4,174,000	-1,720,000	405,000	880,000	-556,000	554,000	28,000	865,000
accrued expenses and other current liabilities	8,421,000	-7,203,000	1,589,000	-1,247,000	10,703,000	-7,351,000	11,669,000	-5,976,000	5,933,000	9,364,000	8,474,000	-7,818,000	6,949,000	-2,530,000	9,959,000
deferred revenue	-10,054,000	24,547,000	16,370,000	11,689,000	-17,457,000	25,285,000	25,745,000	1,892,000	-8,757,000	15,228,000	25,473,000	4,718,000	-3,474,000	13,177,000	27,833,000
other long-term liabilities	-121,000	-1,000	195,000	-130,000	-50,000	-81,000	442,000	627,000	-479,000	-19,000	-15,000	8,000	7,000	10,000	-733,000
net cash from operating activities	6,952,000	24,144,000	17,083,000	-11,410,000	11,612,000	19,395,000	3,821,000	-2,003,000	-17,517,000	22,549,000	12,000	-23,920,000	-16,321,000	17,921,000	-24,530,000
capex	-3,419,000	-1,272,000	-1,878,000	-2,838,000	-4,378,000	-7,954,000	-7,360,000	-3,908,000	-1,175,000	-892,000	-1,934,000	-4,144,000	-8,361,000	-2,266,000	-1,423,000
free cash flows	3,533,000	22,872,000	15,205,000	-14,248,000	7,234,000	11,441,000	-3,539,000	-5,911,000	-18,692,000	21,657,000	-1,922,000	-28,064,000	-24,682,000	15,655,000	-25,953,000
cash flows from investing activities:
cash paid for acquisition, net of cash acquired
purchases of property and equipment	-2,609,000	-217,000	-1,087,000	-1,923,000	-3,309,000	-6,915,000	-6,322,000	-3,012,000	-387,000	-40,000	-1,381,000	-4,222,000	-7,884,000	-1,960,000	-1,200,000
capitalized internal-use software costs	-810,000	-1,055,000	-791,000	-915,000	-1,069,000	-1,039,000	-1,038,000	-896,000	-788,000	-852,000	-553,000	78,000	-477,000	-306,000	-223,000
purchases of marketable securities	-22,751,000	-52,364,000	-38,430,000	-37,446,000	-82,449,000	-59,650,000	-56,137,000	-70,530,000	-75,095,000	-46,297,000	-23,343,000	-70,998,000	-122,343,000	-421,537,000	-4,026,000
maturities of marketable securities	39,325,000	63,215,000	36,267,000	32,086,000	70,000,000	57,000,000	63,000,000	58,448,000	64,803,000	71,486,000	43,300,000	62,399,000	134,708,000	16,000,000	3,700,000
return of principal on marketable securities	7,495,000	113,258,000
net cash from investing activities	-160,550,000	122,837,000	-841,000	-8,198,000	-16,827,000	-10,604,000	-497,000	-15,991,000	-27,785,000	24,297,000	18,023,000	-12,743,000	4,004,000	-407,803,000	-1,749,000
cash flows from financing activities:
proceeds from exercise of common stock options	2,596,000	605,000	3,224,000	1,477,000	1,170,000	1,035,000	1,314,000	-1,384,000	5,122,000	2,211,000	4,119,000	1,802,000	2,781,000	2,630,000	3,721,000
proceeds from stock associated with employee stock purchase plan			2,953,000	0			2,789,000
payments of deferred purchase consideration			0	0	0	-2,916,000	0
net cash from financing activities			6,177,000	1,477,000			4,103,000	1,673,000	5,122,000	2,211,000	4,119,000	1,802,000	2,781,000	2,630,000	463,306,000
effect of foreign currency exchange rate changes on cash, cash equivalents, and restricted cash	-209,000	851,000	-669,000	324,000	238,000	-337,000	331,000	-511,000	-115,000	-180,000	1,043,000	-630,000	-193,000	-1,075,000	-66,000
net change in cash, cash equivalents, and restricted cash	-146,329,000	148,437,000	21,750,000	-17,807,000	945,000	6,573,000	7,758,000	-16,832,000	-40,295,000	48,877,000	23,197,000	-35,491,000	-9,729,000	-388,327,000	436,961,000
cash, cash equivalents, and restricted cash, beginning of period	0	83,592,000	0	0	0	72,131,000	0	0	0	72,623,000	0	0	0	482,973,000	0
cash, cash equivalents, and restricted cash, end of period	-146,329,000	232,029,000	21,750,000	-17,807,000	945,000	78,704,000	7,758,000	-16,832,000	-40,295,000	121,500,000	23,197,000	-35,491,000	-9,729,000	94,646,000	436,961,000
net cash provided by/(used in) financing activities		605,000
adjustments to reconcile net income to net cash provided by/(used in) operating activities:
fixed asset write off
non-cash foreign exchange loss				-317,000			-13,000	-37,000	200,000	310,000			-210,000	505,000
fixed asset write offs
net cash (used in)/provided by financing activities						-1,881,000
proceeds from issuance of common stock upon initial public offering, net of offering costs
investment from redeemable non-controlling interest															0
payment of deferred offering costs															-2,673,000
repurchase of shares related to early exercised options															-2,000
supplemental cash flow disclosure:
cash paid for income taxes, net of refunds											38,000				108,000
non-cash investing and financing activities:
stock-based compensation capitalized to internal-use software											325,000				333,000
net change in capitalized internal-use software development costs in accrued expenses											0				-7,000
unrealized net gain on marketable investment securities
net change to property and equipment											70,000				1,000
vesting of early exercised options											-26,000				144,000
common stock option receivables															-1,155,000
conversion of convertible preferred stock to common stock
deferred offering costs reclassed to stockholders’ equity
asset retirement obligation											26,000
common stock issuance, acquisition
contingent consideration, acquisition
indemnity holdbacks, acquisition
amortization of discount/premium on marketable securities								588,000	520,000	471,000	583,000	538,000	202,000	13,000	56,000
cash paid for acquisition; net of cash acquired								-1,000
non-cash foreign exchange gain											-57,000
repurchase of common shares
unrealized net income on marketable investment securities											2,399,000				-20,000
deferred offering costs included in accounts payable and accrued expenses and other current liabilities
deferred income taxes														4,000	-57,000
benefit from bad debt															186,000
proceeds from issuance of common stock upon initial public offering, net of underwriting discounts
unrealized foreign exchange gain

We provide you with 20 years of cash flow statements for Braze stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Braze stock. Explore the full financial landscape of Braze stock with our expertly curated income statements.

The information provided in this report about Braze stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.